home / stock / vygr / vygr quote
Last: | $8.57 |
---|---|
Change Percent: | -0.91% |
Open: | $8.85 |
Close: | $8.57 |
High: | $8.8541 |
Low: | $8.5 |
Volume: | 387,526 |
Last Trade Date Time: | 05/08/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$8.57 | $8.85 | $8.57 | $8.8541 | $8.5 | 387,526 | 05-08-2024 |
$8.77 | $9 | $8.77 | $9.1 | $8.74 | 385,715 | 05-07-2024 |
$8.94 | $8.9 | $8.94 | $8.99 | $8.65 | 664,456 | 05-06-2024 |
$8.81 | $8.76 | $8.81 | $8.92 | $8.61 | 556,039 | 05-03-2024 |
$8.53 | $8.65 | $8.53 | $8.65 | $8.27 | 435,860 | 05-02-2024 |
$8.36 | $7.8 | $8.36 | $8.56 | $7.8 | 611,415 | 05-01-2024 |
$7.82 | $7.73 | $7.82 | $7.86 | $7.62 | 495,064 | 04-30-2024 |
$7.77 | $7.68 | $7.77 | $7.93 | $7.68 | 433,889 | 04-29-2024 |
$7.62 | $7.4 | $7.62 | $7.71 | $7.32 | 479,915 | 04-26-2024 |
$7.42 | $7.38 | $7.42 | $7.52 | $7.26 | 522,452 | 04-25-2024 |
$7.57 | $7.65 | $7.57 | $7.66 | $7.45 | 312,783 | 04-24-2024 |
$7.65 | $7.6 | $7.65 | $7.78 | $7.57 | 372,354 | 04-23-2024 |
$7.57 | $7.56 | $7.57 | $7.7 | $7.47 | 324,119 | 04-22-2024 |
$7.5 | $7.5 | $7.5 | $7.66 | $7.2831 | 516,459 | 04-19-2024 |
$7.55 | $7.74 | $7.55 | $7.88 | $7.51 | 1,015,265 | 04-18-2024 |
$7.74 | $8.04 | $7.74 | $8.04 | $7.7 | 785,424 | 04-17-2024 |
$7.98 | $8.38 | $7.98 | $8.4 | $7.95 | 398,336 | 04-16-2024 |
$8.24 | $8.36 | $8.24 | $8.4535 | $8.125 | 450,425 | 04-15-2024 |
$8.43 | $8.73 | $8.43 | $8.84 | $8.39 | 565,057 | 04-12-2024 |
$8.78 | $8.9 | $8.78 | $9.02 | $8.75 | 426,084 | 04-11-2024 |
News, Short Squeeze, Breakout and More Instantly...
Voyager Therapeutics Inc. Company Name:
VYGR Stock Symbol:
NASDAQ Market:
Voyager Therapeutics Inc. Website:
- Translational potential of TRACER-derived AAV capsids demonstrated by data across multiple species (murine, porcine, multiple NHPs, human cells) and receptor binding - - Preclinical safety and efficacy demonstrated in Alzheimer’s disease and ALS gene therapies; low IV doses pro...
LEXINGTON, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will report first quarter 2024 financial and operating results after market close on Monday, May 13, 2024. Subseq...
2024-05-05 08:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...